Transforming Drug Discovery

The conversation delves into the three critical phases of drug discovery: unraveling disease biology, converting targets into therapeutic interventions, and enhancing clinical trials through better patient selection. The focus is on the significant challenges in understanding disease mechanisms, which, while complex, hold the potential for the most impactful advancements in patient care. Emphasizing the need for robust science, the discussion highlights the importance of asking the right questions to drive meaningful change in the industry.